Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma
每周一次紫杉醇、卡铂、西妥昔单抗或西妥昔单抗、多西他赛、顺铂和氟尿嘧啶方案,随后进行局部治疗,用于治疗既往未接受过治疗的局部晚期头颈部鳞状细胞癌
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdy549
Haddad, R I; Massarelli, E; Lee, J J; Lin, H Y; Hutcheson, K; Lewis, J; Garden, A S; Blumenschein, G R; William, W N; Pharaon, R R; Tishler, R B; Glisson, B S; Pickering, C; Gold, K A; Johnson, F M; Rabinowits, G; Ginsberg, L E; Williams, M D; Myers, J; Kies, M S; Papadimitrakopoulou, V